Targeted attack on liver tumors tested in new cancer trial
NCT ID NCT04595266
Summary
This study is for people with colorectal cancer that has spread only to the liver and is considered high-risk. It compares standard chemotherapy alone to chemotherapy plus a targeted liver procedure. The goal is to see if the combined approach is better at shrinking tumors and controlling the cancer in the liver.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Complejo Hospitalario de Navarra
Pamplona, Pamplona, Spain
-
H. Univ. Ramón y Cajal
Madrid, Madrid, 28044, Spain
-
Hospital Clínic
Barcelona, Barcelona, Spain
-
Hospital Parc Taulí
Sabadell, Barcelona, Spain
-
Hospital Universitari i Politècnic La Fe
Valencia, Valencia, 46026, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Madrid, Spain
-
Hospital Universitario La Paz
Madrid, Madrid, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, Spain
Conditions
Explore the condition pages connected to this study.